MISAA

MISAA

Closed: Dec. 2024

About this raise

MISAA, with a valuation of $10 million, is raising funds on NetCapital. The company is developing a 15-minute blood test for tacrolimus, required for organ transplant patients. MISAA’s TAC Assay will be a rapid test that will be usable in labs, POC, and homes and could enhance transplant outcomes for patients. The rapid test is also expected to impact the lives of recipients, caregivers, and service providers. Reuben Sandler founded MISAA in July 2023. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1 million. The campaign proceeds will be used for labor, clinical trials, product development, materials, consulting, admin, and overhead.

Expand

Investment Overview

Invested this round: $13,158

Deal Terms

Total Commitments ($USD)

Platform
Netcapital
Start Date
01/19/2024
Close Date
12/20/2024
Min. Goal
$10,000
Max Goal
$1,000,000
Min. Investment

$99

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.00

Pre-Money Valuation

$10,000,000

Company & Team

Company

Year Founded
2023
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B2C
Margin
Medium
Capital Intensity
High
Location
Torrance, California
Business Type
Growth
Company Website
Visit Website

Team

Employees
5
Prior Founder Exits?
No
Founder Name
Reuben Sandler
Title
CEO

Financials

as of Fiscal Year 2022
 Revenue
$0
 Cash on Hand
$0

Summary Profit and Loss Statement

FY 2022 FY 2021

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$0

$0

Summary Balance Sheet

FY 2022 FY 2021

Cash

$0

$0

Accounts Receivable

$0

$0

Total Assets

$0

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$0
Grants
$4,000,000
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
12/20/2024 Netcapital $10,000,000 $13,158 Equity - Common Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
MISAA on NetCapital 2024
Platform: Netcapital
Security Type: Equity - Common
Valuation: $10,000,000
Price per Share: $1.00

Follow company

Follow MISAA on NetCapital 2024

Buy MISAA's Deal Report

Warning: according to the close date for this deal, MISAA may no longer be accepting investments.

MISAA Deal Report

Get Kingscrowd's comprehensive report on MISAA including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether MISAA is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the MISAA deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge